All Government articles
View all stories with this category.
-
BusinessRussian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
Opinion
Why scientists are worried by a second term for Trump
Another four years could be very problematic
-
News
Science community holds its breath as US election looms
The election is a high stakes affair for university researchers and science advocates, who overwhelmingly back Biden
-
News
EPA settles Gold King mine disaster five years later
Utah state will receive $220 million as part of settlement over 2015 accident that spilled toxic waste into waterways
-
Business
Questions surround deadly Beirut blast
Ammonium nitrate explosion that killed at least 135 appears to have been caused by poorly-stored cargo from an abandoned vessel
-
Business
Deadly Indian incidents highlight relaxed regulations
Concern over human and environmental cost of reforms aimed at ease of doing business
-
Business
Appeals court cuts damages further in glyphosate cancer case
Judgment retains verdict that Bayer-Monsanto’s herbicide caused US man’s cancer
-
Opinion
Looking beyond the next wave
We need to apply lessons from Covid-19 to tackle antimicrobial resistance and climate change
-
News
Horizon Europe budget cut prompts backlash from ERC’s scientific council
Proposed reduction attacked as ‘retrograde step’
-
News
Russian cyber spies are targeting Covid-19 vaccine research
Intelligence officials warn that Russian hackers are trying to steal intellectual property from UK, US and Canadian organisations working on novel coronavirus vaccines
-
News
Criminal charges for undeclared Chinese research ties mount in the US
Ohio State University immunologist is latest to be swept up in probe into undisclosed foreign funding
-
Business
What are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
News
US environmental body ditches ban on grantees on advisory panels
After several legal defeats, the EPA has backed down on controversial policy
-
Business
Bayer commits over $10bn to resolve legacy Monsanto lawsuits
Agreement settles about 75% of Roundup-related cases and resolves PCB and dicamba litigation
-
Business
Scrambling and gambling to scale up Covid-19 medicines
Organisations work towards making billions of doses of products not yet proven to work
-
News
Roadmap plans route out of pandemic purgatory for UK research
Ambition applauded by science community but researchers yet to be sold on its substance
-
News
EU science programme will be hurt by Brexit but will survive
Network analysis suggests excellent science pillar of Horizon framework will be hardest hit
-
News
Fears that US clampdown on student visas will hamstring nation’s research
The country’s universities could suffer if restrictions aren’t eased soon
-
News
Harvard University’s former chemistry head indicted for lying about China ties
Charles Lieber faces up to five years in prison if convicted
-
News
Amid pandemic, UK is on track to double science funding by 2024
Government making good on promise of increasing R&D spending to £22 billion
